PDIA3 and obstructive sleep apnea syndrome: This study employed bioinformatics approaches to investigate the biological pathways and regulatory mechanisms involving PRGs, with a focus on HIF1A and PDIA3 as biomarkers, providing new avenues for OSA research and treatment.